RPHKARDIA (MIBI)
copper tetraethylammonium tetrafluoroborate
Image for illustration purposes only.
Presentation: Kit containing 5 vials of lyophilized powder for injectable solution. Sterile product, non-pyrogenic and under nitrogen atmosphere for complexation with the radioisotope metastable technetium-99m (99mTc).
Indications: myocardial perfusion agent used in the evaluation of coronary artery diseases. It can also be used in parathyroid and breast scintigraphy, and to determine tumor viability.
Storage: 2-8 ºC
Labeling volume: 3-6 mL
Labeling activity: 600 mCi
Stability post-labeling: 12 hours in room temperature. (15 to 30 ºC).
Product expiration date: 18 moths
Number of vials per kit: 5
Registration: MS.1.7359.0002-001-9
AVAILABLE BY PRESCRIPTION ONLY – RESTRICTED USE TO HOSPITALS.
IF SYMPTOMS PERSIST, A DOCTOR SHOULD BE CONSULTED.
Contraindications, warnings, adverse reactions, drug interactions, precautions and posology: refer to package leaflet.
R2Pharma products are available only by means of medical prescription from a licensed physician.
IF SYMPTOMS PERSIST, A DOCTOR SHOULD BE CONSULTED.
Contraindications, warnings, adverse reactions, drug interactions, precautions and posology: refer to package leaflet.
The content of this page is destined to health professionals.